Current Rheumatology Reports

, Volume 10, Issue 2, pp 110–117 | Cite as

Calcium and vitamin D: Skeletal and extraskeletal health

Article

Abstract

Vitamin D is known for its role in calcium homeostasis for optimal skeletal health. It was previously believed that only elderly or hospitalized patients were at risk for vitamin D insufficiency, but many people in the general US population have insufficient levels of 25-hydroxyvitamin D (25[OH]D). According to the Third National Health and Nutrition Examination Survey, 61% of white and 91% of black Americans suffer from vitamin D insufficiency (25[OH]D < 32 ng/mL). Recent studies have demonstrated that a minimum 25(OH)D level of 32 ng/mL is necessary for optimal protection from fracture and intestinal absorption of calcium. Recently, vitamin D has been recognized as important for extraskeletal functions such as immune function, cancer prevention, and hypertension prevention. We review the role of vitamin D in skeletal health and present data on vitamin D in other extraskeletal diseases, with special emphasis on the rheumatology patient.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Holick MF: Vitamin D deficiency. N Engl J Med 2007, 357:266–281. [Comment in: N Engl J Med 2007, 357:1980–1981; author reply 1981–1982. N Engl J Med 2007, 357:1981; author reply 1981–1982. N Engl J Med 2007, 357:1981; author reply 1981–1982. N Engl J Med 2007, 357:1981; author reply 1981–1982.]PubMedCrossRefGoogle Scholar
  2. 2.
    Tangpricha V, Spina C, Yao M, et al.: Vitamin D deficiency enhances the growth of MC-26 colon cancer xenografts in Balb/c mice. J Nutr 2005, 135:2350–2354.PubMedGoogle Scholar
  3. 3.
    Zhou C, Assem M, Tay JC, et al.: Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia. J Clin Invest 2006, 116:1703–1712. [Comment in: J Clin Invest 2006, 116:2564.]PubMedCrossRefGoogle Scholar
  4. 4.
    Walters JR, Balesaria S, Chavele KM, et al.: Calcium channel TRPV6 expression in human duodenum: different relationships to the vitamin D system and aging in men and women. J Bone Miner Res 2006, 21:1770–1777.PubMedCrossRefGoogle Scholar
  5. 5.
    Pattanaungkul S, Riggs BL, Yergey AL, et al.: Relationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D [1,25(OH)2D] levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D action. J Clin Endocrinol Metab 2000, 85:4023–4027.PubMedCrossRefGoogle Scholar
  6. 6.
    Walters JR, Balesaria S, Khair U, et al.: The effects of vitamin D metabolites on expression of genes for calcium transporters in human duodenum. J Steroid Biochem Mol Biol 2007, 103:509–512.PubMedCrossRefGoogle Scholar
  7. 7.
    Amling M, Priemel M, Holzmann T, et al.: Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 1999, 140:4982–4987.PubMedCrossRefGoogle Scholar
  8. 8.
    Hollis BW, Wagner CL: Normal serum vitamin D levels. N Engl J Med 2005, 352:515–516; author reply 515–516.PubMedCrossRefGoogle Scholar
  9. 9.
    Chapuy MC, Preziosi P, Maamer M, et al.: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7:439–443.PubMedCrossRefGoogle Scholar
  10. 10.
    Heaney RP, Dowell MS, Hale CA, Bendich A: Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003, 22:142–146.PubMedGoogle Scholar
  11. 11.
    Chapuy MC, Arlot ME, Duboeuf F, et al.: Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992, 327:1637–1642.PubMedGoogle Scholar
  12. 12.
    Chapuy MC, Pamphile R, Paris E, et al.: Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002, 13:257–264.PubMedCrossRefGoogle Scholar
  13. 13.
    Trivedi DP, Doll R, Khaw KT: Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003, 326:469.PubMedCrossRefGoogle Scholar
  14. 14.
    Dawson-Hughes B, Harris SS, Krall EA, Dallal GE: Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997, 337:670–676. [Comment in: ACP J Club 1998, 128:47. N Engl J Med 1997, 337:701–702.]PubMedCrossRefGoogle Scholar
  15. 15.
    Larsen ER, Mosekilde L, Foldspang A: Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004, 19:370–378.PubMedCrossRefGoogle Scholar
  16. 16.
    Thomas MK, Lloyd-Jones DM, Thadhani RI, et al.: Hypovitaminosis D in medical inpatients. N Engl J Med 1998, 338:777–783. [Comment in: N Engl J Med 1998, 339:344–345; author reply 345–346. N Engl J Med 1998, 339:345–346. N Engl J Med 1998, 338:828–829.]PubMedCrossRefGoogle Scholar
  17. 17.
    van der Wielen RP, Löwik MR, van den Berg H, et al.: Serum vitamin D concentrations among elderly people in Europe. Lancet 1995, 346:207–210.PubMedCrossRefGoogle Scholar
  18. 18.
    Holick MF, Siris ES, Binkley N, et al.: Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005, 90:3215–3224.PubMedCrossRefGoogle Scholar
  19. 19.
    Tangpricha V, Pearce EN, Chen TC, Holick MF: Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002 112:659–662.PubMedCrossRefGoogle Scholar
  20. 20.
    Jackson RD, LaCroix AZ, Gass M, et al.; Women’s Health Initiative Investigators: Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006, 354:669–683. [Erratum in: N Engl J Med 2006, 354:1102. Comment in: ACP J Club 2006, 145:4–5. Evid Based Nurs 2006, 9:114. N Engl J Med 2006, 354:750–752. N Engl J Med 2006, 354:2285–2287; author reply 2285–2287. N Engl J Med 2006, 354:2285–2287; author reply 2285–2287. N Engl J Med 2006, 354:2285–2287; author reply 2285–2287.]PubMedCrossRefGoogle Scholar
  21. 21.
    Porthouse J, Cockayne S, King C, et al.: Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005, 330:1003. [Comment in: ACP J Club 2005, 143:72–74. Age Ageing 2005, 34:542–544. BMJ 2005, 331:108–109; author reply 109. BMJ 2005, 331:108; author reply 109. BMJ 2005, 331:108; author reply 109.]PubMedCrossRefGoogle Scholar
  22. 22.
    Grant AM, Avenell A, Campbell MK, et al.: Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005, 365:1621–1628. [Comment in: ACP J Club 2005, 143:72–74. J Fam Pract 2005, 54:658. Lancet 2005, 366:543; author reply 543–544. Lancet 2005, 366:543; author reply 543–544. Lancet 2005 366:544. Lancet 2005, 365:1599–1600.]PubMedCrossRefGoogle Scholar
  23. 23.
    Lips P, Graafmans WC, Ooms ME, et al.: Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo-controlled clinical trial. Ann Intern Med 1996, 124:400–406. [Comment in: ACP J Club 1996, 125:16.]PubMedGoogle Scholar
  24. 24.
    Meyer HE, Smedshaug GB, Kvaavik E, et al.: Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002, 17:709–715.PubMedCrossRefGoogle Scholar
  25. 25.
    Boonen S, Lips P, Bouillon R, et al.: Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007, 92:1415–1423.PubMedCrossRefGoogle Scholar
  26. 26.
    Bischoff-Ferrari HA, Dawson-Hughes B: Where do we stand on vitamin D? Bone 2007, 41(1 Suppl 1):S13–S19.PubMedCrossRefGoogle Scholar
  27. 27.
    Holick MF: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353–373. [Comment in: Mayo Clin Proc 2006, 81:297–299.]PubMedCrossRefGoogle Scholar
  28. 28.
    Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al.: Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged > or = 60 y. Am J Clin Nutr 2004, 80:752–758.PubMedGoogle Scholar
  29. 29.
    Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al.: Effect of vitamin D on falls: a meta-analysis. JAMA 2004, 291:1999–2006.PubMedCrossRefGoogle Scholar
  30. 30.
    Cantorna MT, Zhu Y, Froicu M, Wittke A: Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004, 80(6 Suppl):1717S–1720S.PubMedGoogle Scholar
  31. 31.
    Vaisberg MW, Kaneno R, Franco MF, Mendes NF: Influence of cholecalciferol (vitamin D3) on the course of experimental systemic lupus erythematosus in F1 (NZBxW) mice. J Clin Lab Anal 2000, 14:91–96.PubMedCrossRefGoogle Scholar
  32. 32.
    Merlino LA, Curtis J, Mikuls TR, et al.; Iowa Women’s Health Study: Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 2004, 50:72–77. [Comment in: Arthritis Rheum 2006, 54:3719–3720.]PubMedCrossRefGoogle Scholar
  33. 33.
    Costenbader KH, Feskanich D, Benito-Garcia E, et al.: Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis 2007, [Epub ahead of print].Google Scholar
  34. 34.
    Munger KL, Levin LI, Hollis BW, et al.: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832–2838.PubMedCrossRefGoogle Scholar
  35. 35.
    Liu PT, Stenger S, Li H, et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770–1773.PubMedCrossRefGoogle Scholar
  36. 36.
    Mathieu C, Gysemans C, Giulietti A, Bouillon R: Vitamin D and diabetes. Diabetologia 2005, 48:1247–1257.PubMedCrossRefGoogle Scholar
  37. 37.
    Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 2007, 20:713–719.PubMedCrossRefGoogle Scholar
  38. 38.
    Ford ES, Ajani UA, McGuire LC, Liu S: Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care 2005, 28:1228–1230.PubMedCrossRefGoogle Scholar
  39. 39.
    Judd SE, Nanes MS, Ziegler TR, et al.: Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008, 87:136–141.PubMedGoogle Scholar
  40. 40.
    Pfeifer M, Begerow B, Minne HW, et al.: Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001, 86:1633–1637.PubMedCrossRefGoogle Scholar
  41. 41.
    Hsia J, Heiss G, Ren H, et al.; Women’s Health Initiative Investigators: Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007, 115:846–854. [Erratum in: Circulation 2007, 115:e466. Comment in: Circulation 2007, 115:827–828. Circulation 2007, 116:e85; author reply e87. Circulation 2007, 116:e86; author reply e87.]PubMedCrossRefGoogle Scholar
  42. 42.
    Autier P, Gandini S: Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167:1730–1737.PubMedCrossRefGoogle Scholar
  43. 43.
    Lappe JM, Travers-Gustafson D, Davies KM, et al.: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007, 85:1586–1591. [Comment in: Am J Clin Nutr 2007, 86:1804–1805; author reply 1805–1806. Am J Clin Nutr 2007, 86:1549; author reply 1549–1550.]PubMedGoogle Scholar
  44. 44.
    Huybers S, Naber TH, Bindels RJ, Hoenderop JG: Prednisolone-induced Ca2+ malabsorption is caused by diminished expression of the epithelial Ca2+ channel TRPV6. Am J Physiol Gastrointest Liver Physiol 2007, 292:G92–G97.PubMedCrossRefGoogle Scholar
  45. 45.
    Recker RR: Calcium absorption and achlorhydria. N Engl J Med 1985, 313:70–73.PubMedGoogle Scholar
  46. 46.
    Sakhaee K, Bhuket T, Adams-Huet B, Rao DS: Meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate. Am J Ther 1999, 6:313–321. [Comment in: Am J Ther 2001, 8:73–74. Am J Ther 2001, 8:74–77.]PubMedCrossRefGoogle Scholar
  47. 47.
    Heaney RP, Dowell MS, Bierman J, et al.: Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 2001, 20:239–246.PubMedGoogle Scholar
  48. 48.
    Recker RR, Bammi A, Barger-Lux MJ, Heaney RP: Calcium absorbability from milk products, an imitation milk, and calcium carbonate. Am J Clin Nutr 1988, 47:93–95.PubMedGoogle Scholar
  49. 49.
    Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004, 89:5387–5391.PubMedCrossRefGoogle Scholar
  50. 50.
    Kamen DL, Cooper GS, Bouali H, et al.: Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 2006, 5:114–117.PubMedCrossRefGoogle Scholar
  51. 51.
    Harvey JA, Zobitz MM, Pak CY: Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 1988, 3:253–258.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Natasha Khazai
  • Suzanne E. Judd
  • Vin Tangpricha
    • 1
  1. 1.Woodruff Memorial Research BuildingAtlantaUSA

Personalised recommendations